Antimicrob Agents Chemother. 1990 Mar;34(3):390-3. doi: 10.1128/AAC.34.3.390.

Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.

Antimicrobial agents and chemotherapy

W M Dunne

PMID: 2334150 PMCID: PMC171602 DOI: 10.1128/AAC.34.3.390
Free PMC Article

Abstract

The density of the biofilm layer produced on a plastic surface by 23 clinical isolates and 1 reference strain of slime-positive, coagulase-negative staphylococci was measured following growth in subinhibitory concentrations (sub-MICs) of cefamandole or vancomycin ranging from 2 to 0.008 micrograms/ml. All strains were susceptible to less than or equal to 2 micrograms of each agent per ml. The mean biofilm density produced by each strain was calculated from a total of eight determinations at each sub-MIC and was compared with the mean biofilm density of a drug-free control after correcting for differences in growth. The results showed that the density of the biofilm layer produced by 10 (42%) of 24 strains and 13 (54%) of 24 strains was significantly increased (P less than 0.006) at one or more sub-MICs of cefamandole or vancomycin, respectively. In contrast, the density of the biofilm produced by 9 (38%) of 24 and 2 (8%) of 24 strains was significantly reduced at one or more sub-MICs of cefamandole and vancomycin, respectively, and the biofilm density of 7 of these strains was decreased only when the sub-MIC was one-half the MIC. The biofilm density of six strains (five versus cefamandole and one versus vancomycin) was both enhanced and reduced by different sub-MICs of the same agent. None of the strains produced a detectable biofilm at or above the MIC for the strain. These data indicate that antimicrobial agents such as cefamandole or vancomycin could potentially enhance the biofilm matrix produced by certain slime-positive, coagulase-negative staphylococci on the surface of a biomedical implant if concentrations of these agents fall below the MIC for the infecting strain.

Similar articles

Cited by

References

1. Infect Immun. 1982 Jul;37(1):318-26 - PubMed
2. J Clin Microbiol. 1985 Dec;22(6):996-1006 - PubMed
3. J Clin Microbiol. 1983 Aug;18(2):258-69 - PubMed
4. Ann Intern Med. 1983 Dec;99(6):834-9 - PubMed
5. J Infect Dis. 1986 Feb;153(2):332-9 - PubMed
6. J Clin Microbiol. 1986 May;23(5):809-12 - PubMed
7. Antimicrob Agents Chemother. 1986 May;29(5):789-96 - PubMed
8. Infect Immun. 1986 Oct;54(1):13-20 - PubMed
9. J Infect Dis. 1987 Oct;156(4):548-54 - PubMed
10. J Infect Dis. 1988 Jan;157(1):71-7 - PubMed
11. Pediatr Infect Dis J. 1987 Nov;6(11):1031-5 - PubMed
12. Antimicrob Agents Chemother. 1984 May;25(5):666-8 - PubMed
13. J Clin Microbiol. 1984 Sep;20(3):500-5 - PubMed
14. J Clin Microbiol. 1985 Dec;22(6):1025-9 - PubMed
15. J Clin Microbiol. 1988 Apr;26(4):613-7 - PubMed
16. J Infect Dis. 1982 Oct;146(4):479-82 - PubMed

Substances

• Coagulase
• Plastics
• Cefamandole
• Vancomycin

MeSH terms

• Cefamandole / pharmacology
• Cell Division / drug effects
• Coagulase / metabolism
• Extracellular Matrix / drug effects
• Plastics
• Staphylococcus / enzymology
• Staphylococcus / genetics
• Staphylococcus / metabolism
• Vancomycin / pharmacology

Publication Types

• Journal Article

LinkOut - more resources

• Full Text Sources
  • Atypon
  • Europe PubMed Central
  • PubMed Central
• Other Literature Sources
  • The Lens - Patent Citations